VMI

VHCP Management III Portfolio holdings

AUM $504M
1-Year Est. Return 678.37%
This Quarter Est. Return
1 Year Est. Return
+678.37%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$504M
AUM Growth
+$342M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
26
New
Increased
Reduced
Closed

Top Buys

1
+$115M
2
+$29.9M
3
+$25.2M
4
FTSV
Forty Seven, Inc. Common Stock
FTSV
+$20.3M
5
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$19.7M

Top Sells

1
+$15.9M
2
+$11M
3
+$7.76M
4
PTGX icon
Protagonist Therapeutics
PTGX
+$7M
5
AXSM icon
Axsome Therapeutics
AXSM
+$6.55M

Sector Composition

1 Healthcare 97.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AXSM icon
1
Axsome Therapeutics
AXSM
$6.57B
$160M 31.77%
1,547,994
-63,335
CNST
2
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$119M 23.54%
2,516,242
+2,449,575
MIST icon
3
Milestone Pharmaceuticals
MIST
$169M
$33.1M 6.57%
2,066,529
RLMD icon
4
Relmada Therapeutics
RLMD
$75M
$29.9M 5.95%
+767,938
ETNB icon
5
89bio
ETNB
$2.2B
$25.2M 5%
+958,765
TXG icon
6
10x Genomics
TXG
$1.64B
$22.9M 4.54%
300,000
FTSV
7
DELISTED
Forty Seven, Inc. Common Stock
FTSV
$20.3M 4.04%
+516,381
ITCI
8
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$19.7M 3.92%
+575,000
ISEE
9
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$14.6M 2.9%
+1,699,797
KALV icon
10
KalVista Pharmaceuticals
KALV
$583M
$11M 2.19%
619,905
-17,979
ADVM icon
11
Adverum Biotechnologies
ADVM
$93.6M
$10.9M 2.16%
+94,623
MRNS
12
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$10.8M 2.15%
1,254,041
+625,000
MRSN icon
13
Mersana Therapeutics
MRSN
$52M
$8.95M 1.78%
+62,456
MYOV
14
DELISTED
Myovant Sciences Ltd.
MYOV
$7.07M 1.4%
+455,255
NXTC icon
15
NextCure
NXTC
$29M
$6.74M 1.34%
+9,974
OBSV
16
DELISTED
ObsEva SA Ordinary Shares
OBSV
$3.1M 0.61%
810,264
-349,525
PTGX icon
17
Protagonist Therapeutics
PTGX
$4.77B
$571K 0.11%
80,929
-991,419
BLPH
18
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$134K 0.03%
25,597
-135,551
BCRX icon
19
BioCryst Pharmaceuticals
BCRX
$1.46B
– –
-2,708,207
KNSA icon
20
Kiniksa Pharmaceuticals
KNSA
$2.89B
– –
-277,137
KA
21
DELISTED
Kineta, Inc. Common Stock
KA
– –
-1,580
TCDA
22
DELISTED
Tricida, Inc. Common Stock
TCDA
– –
-80,348
RDUS
23
DELISTED
Radius Health, Inc.
RDUS
– –
-23,131
PRVL
24
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
– –
-4,408
RARX
25
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
– –
-670,350
1
2